Skip to main content
. 2022 Feb;10(3):129. doi: 10.21037/atm-21-6774

Table 2. Genes hosting variants with potential risk of sporadic DCM in the DCM cohort being studied.

Gene Prevalencea of variants with risk of sporadic DCM P valuec Prevalencea of variants Number of variants with risk of sporadic DCM P valued Number of total variants
MYBPC3 9 (13.6%)b 0.000* 11 6 0.010* 7
SCN5A 9 (13.6%) 0.000* 36 7 0.002* 10
MYH7 8 (12.1%) 0.001* 8 8 0.001* 8
MYPN 6 (9.0%) 0.011* 142 4 0.140 10
LDB3 5 (7.6%) 0.039* 14 5 0.034* 8
RBM20 4 (6.1%) 0.114 135 4 0.140 9
LAMA4 4 (6.1%) 0.114 236 3 0.261 10
SGCD 3 (4.5%) 0.277 3 3 0.261 3
ACTN2 2 (3.0%) 0.546 8 2 0.528 3
TNNT2 2 (3.0%) 0.546 6 1 0.830 2
MYH6 1 (1.5%) 0.840 34 1 0.830 2
ABCC9 1 (1.5%) 0.840 2 1 0.830 7
DES 1 (1.5%) 0.840 1 1 0.830 1
LMNA 1 (1.5%) 0.840 1 1 0.830 1
TPM1 1 (1.5%) 0.840 1 1 0.830 1
TAZ 1 (1.5%) 0.840 1 1 0.830 1
VCL 0 (0%) 1.000 2 0 1.000 2
ACTC1 0 (0%) 0 0 0
PLN 0 (0%) 0 0 0
PSEN1 0 (0%) 0 0 0
PSEN2 0 (0%) 0 0 0
TCAP 0 (0%) 0 0 0
TMPO 0 (0%) 0 0 0
TNNI3 0 (0%) 0 0 0

a, prevalence was designated as the sum of patients carrying a variant (either homozygous or heterozygous) in each gene. When prevalence was calculated, variants co-occurring in a gene were counted separately. Likewise, variants co-occurring in a patient were also counted separately. b, prevalence in this column was also expressed as a percentage of the total patients in the DCM cohort. c,d, P values were computed using Poisson distribution as described in the Methods section. The means of the fitted Poisson distribution (λ) were 0.97 and 0.95, respectively. Only those genes that contained nonsynonymous variants were included in the computation. *, P<0.05.